Dr. Matthew Hakimi is a cardiac electrophysiologist at Cedars-Sinai Medical Center in Los Angeles and Medical Director at Adagio Medical, where he leads the FulcrumVT IDE clinical trial and guides product development for the company’s ultra-low temperature ablation (ULTA) platform. His clinical practice focuses on complex ventricular arrhythmia ablation, and he sits at the intersection of clinical electrophysiology and medical device innovation — a perspective he brings to KOL panels, industry advisory work, and academic collaborations across the EP community. He trained at UC Berkeley, the David Geffen School of Medicine at UCLA, and Weill Cornell Medicine, where he completed his cardiac electrophysiology fellowship.